Anti-actin monoclonal antibodies were prepared using phalloidin-stabilized actin that was purified from pea roots by DNase I affinity chromatography. One monoclonal antibody, designated mAb3H 1 1, bound plant actin in preliminary screenings and was further analyzed. Immunoblot analysis showed that t
?-actin specific monoclonal antibody
β Scribed by Gimona, Mario ;Vandekerckhove, Joel ;Goethals, Marc ;Herzog, Monika ;Lando, Zeev ;Small, J. Victor
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- English
- Weight
- 1004 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0886-1544
No coin nor oath required. For personal study only.
β¦ Synopsis
Using a synthetic peptide mimicking the NH,-terminus of p-actin we have raised a monoclonal antibody specific for this cytoplasmic actin isoform. Specificity of the antibody was demonstrated by its labelling of the actin polypeptide only in tissues containing the p isoform, by its exclusive recognition of the synthetic p-actin peptide amongst those mimicking all six vertebrate isoactins, and by its selective recognition of the p-actin spot in two-dimensional electrophoresis gels of smooth muscle extracts. The antibody bound to actin filaments in both living and fixed fibroblasts where it labelled the stress fiber bundles and, more predominantly, the peripheral actin rich lamellipodia. The characteristics of the antibody indicate that it should serve as a useful tool for studying isoactin distribution and function.
π SIMILAR VOLUMES
Prostate-specific antigen (PSA) is the most important tumor marker for early detection and monitoring of prostate cancer (PCa) patients. PSA is also elevated in many patients with benign prostatic hyperplasia (BPH). The study of the serum PSA forms, free PSA (f-PSA) and PSA complexed with a,-antichy
A monoclonal antibody (MAb) specific for rainbow trout thrombocytes was produced and its reactivity was demonstrated by flow cytometry and immuno-electron microscopy. Flow cytometry analysis showed that this MAb (TTL-7D11) reacted positively with about 30% of the peripheral blood leucocytes (PBL) an